Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Gemphire Therapeutics Inc.

NASDAQ: GEMPHealthcare / Biotechnology / USA
1.06-0.06-5.36%Vol 33 7961Y Perf -86.63%
Dec 10th, 2018 11:32
BID1.05 ASK1.08
Open1.11 Previous Close1.12
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.00 
Analyst Rating
Hold 3.00
Potencial %
88.68 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)15 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
2.17 
Earnings Date
12th Nov 2018

Today's Price Range

1.051.12

 

52wk Range

0.8311.43

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-17.04%
3 Months
-44.28%
6 Months
-84.25%
1 Year
-86.63%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
GEMP1.06-0.0600-5.36
AAPL165.39-3.1000-1.84
GOOG1 038.301.72000.17
MSFT105.150.33000.31
XOM75.36-2.2800-2.94
WFC48.77-1.4900-2.96
JNJ143.05-2.3800-1.64
FB140.863.44002.50
GE6.87-0.1400-2.00
JPM100.23-3.0600-2.96
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.10
Current Ratio
3.30
Long Term Debt to Total Capital
0.37
Total Debt to Equity
0.93
Interest Coverage
-
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.31
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.70
Cash Flow Per Share
-2.30
Price to Tangible Book
1.31
Book Value per Share
1.05
Enterprise Value (in ths.)
1 839
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-256.97
Return on Assets (5Y Avg)
-
ROA last 12 Months
-104.65
Return on Capital (5Y Avg)
-
ROC last 12 Months
-120.05
Return on invested Capital Q
-26.33
Return on invested Capital Y
-149.68
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.45-0.434.44
Q02 2018-0.51-0.477.84
Q01 2018-0.59-0.581.69
Q04 2017-0.72-0.6312.50
Q03 2017-0.72-0.82-13.89
Q02 2017-0.80-0.747.50
Q01 2017-0.61-0.79-29.51
Q04 2016--0.78-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.3915.22Positive
12/2018 FY-1.885.53Positive
3/2019 QR-0.420.00-
12/2019 FY-2.053.76Positive
Next Report Date-
Estimated EPS Next Report-0.44
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume33 796
Shares Outstanding (in ths.)14 270
Trades Count105
Dollar Volume52 176
Avg. Volume427 314
Avg. Weekly Volume316 313
Avg. Monthly Volume127 648
Avg. Quarterly Volume289 004

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

43%57%

Bearish Bullish

56%44%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
1 (33.33 %)
1 (25.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (66.67 %)
3 (75.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Moderate Buy
2.33
Moderate Buy
2.50

There are no comments yet.

News